Cargando…

Annexin A1 is a potential biomarker of bone metastasis in small cell lung cancer

Small cell lung cancer (SCLC) is a subtype of lung cancer with a poor prognosis, with bone metastasis being one of the main causes of treatment failure. Therefore, investigating new biomarkers associated with bone metastasis may result in positive treatment outcomes. The present study detected the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peng, Min, Jie, Wu, Hong, Zhang, Helong, Wang, Chaoli, Tan, Guangguo, Zhang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798093/ https://www.ncbi.nlm.nih.gov/pubmed/33552260 http://dx.doi.org/10.3892/ol.2020.12402

Ejemplares similares

The Biological Effects of Dickkopf1 on Small Cell Lung Cancer Cells and Bone Metastasis
por: Pang, Hailin, et al.
Publicado: (2017)

Annexin 1–nuclear factor‐κB–microRNA‐26a regulatory pathway in the metastasis of non‐small cell lung cancer
por: Guan, Xiaoying, et al.
Publicado: (2019)

Risk factors for bone metastasis in patients with primary lung cancer: A systematic review
por: Niu, Yujie, et al.
Publicado: (2019)

Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma
por: Ağababaoğlu, İsmail, et al.
Publicado: (2017)

Membrane-cytoplasm translocation of annexin A4 is involved in the metastasis of colorectal carcinoma
por: Peng, Ya, et al.
Publicado: (2021)

Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma: Erratum
Publicado: (2017)

Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma
por: Kotepui, Kwuntida U, et al.
Publicado: (2022)

Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis
por: Herrera-López, Ema Elvira, et al.
Publicado: (2023)

Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients
por: Biaoxue, Rong, et al.
Publicado: (2012)

Annexin A2 and FTH1 are potential biomarkers for lupus nephritis
por: Zhou, Yanni, et al.
Publicado: (2018)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

Potential Biomarkers in Mouse Myocardium of Doxorubicin-Induced Cardiomyopathy: A Metabonomic Method and Its Application
por: Tan, Guangguo, et al.
Publicado: (2011)

Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas
por: Li, Shuang, et al.
Publicado: (2017)

Therapeutic Potential of Annexins in Sepsis and COVID-19
por: Mui, Louise, et al.
Publicado: (2021)

Annexin A3 Knockdown Suppresses Lung Adenocarcinoma
por: Liu, Ying-Fu, et al.
Publicado: (2016)

Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis
por: Sandri, Silvana, et al.
Publicado: (2023)

Identification of the potential ferroptosis key genes in lung cancer with bone metastasis
por: Zhou, Qin, et al.
Publicado: (2023)

Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer Biomarkers
por: Perez, Gloria I., et al.
Publicado: (2023)

Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
por: Chai, Xupeng, et al.
Publicado: (2021)

Proteomics score: a potential biomarker for the prediction of prognosis in non-small cell lung cancer
por: Peng, Jie, et al.
Publicado: (2019)

Expression of annexin II in gastric carcinoma and its role in gastric cancer metastasis
por: Han, Feng, et al.
Publicado: (2017)

The annexins
por: Moss, Stephen E, et al.
Publicado: (2004)

Comprehensive circular RNA expression profile of lung adenocarcinoma with bone metastasis: Identification of potential biomarkers
por: Cai, Ying, et al.
Publicado: (2022)

Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells
por: Feng, Xiaomin, et al.
Publicado: (2017)

Therapeutic potential for targeting Annexin A1 in fibrotic diseases
por: Yan, Zhibin, et al.
Publicado: (2022)

Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer
por: Yang, Xiao-Rong, et al.
Publicado: (2020)

Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis
por: DONG, ZHIZHEN, et al.
Publicado: (2014)

Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model
por: Jin, Yanling, et al.
Publicado: (2013)

Annexin A3 and cancer
por: Liu, Chao, et al.
Publicado: (2021)

Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
por: Zhang, Li, et al.
Publicado: (2021)

Annexin A1 in the nervous and ocular systems
por: Wang, Aijia, et al.
Publicado: (2023)

Prediction of bone metastasis in non-small cell lung cancer based on machine learning
por: Li, Meng-Pan, et al.
Publicado: (2023)

The Association of Annexin A1 and Chemosensitivity to Osimertinib in Lung Cancer Cells
por: Chuang, Min-Chun, et al.
Publicado: (2021)

Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study
por: Zhou, Tao, et al.
Publicado: (2017)

Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer
por: Zhou, Zhen, et al.
Publicado: (2012)

Annexin-A1: Therapeutic Potential in Microvascular Disease
por: Purvis, Gareth S. D., et al.
Publicado: (2019)

Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer
por: Du, Ruikai, et al.
Publicado: (2018)

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
por: LIU, ZHIKUN, et al.
Publicado: (2013)

Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
por: Shaker, Mohamed K, et al.
Publicado: (2017)

Annexins in Glaucoma
por: Yap, Timothy E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_puuavudebaocgp6fnijtdol9ar